PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This is a Phase 3 Study to Compare the Pharmacokinetics, Efficacy and Safety between CT-P10,
Rituxan and MabThera in Patients with Rheumatoid Arthritis.